CROX Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Loading...
Crocs Inc (CROX) is not a strong buy for a beginner, long-term investor at this time. Despite a recent surge in stock price driven by better-than-expected Q4 earnings and positive revenue growth, the company's financial performance shows significant YoY declines in net income, EPS, and gross margin. Additionally, analysts have downgraded the stock due to concerns about U.S. demand, wholesale challenges, and limited near-term catalysts. While hedge funds are buying and options sentiment leans slightly bullish, technical indicators suggest the stock is overbought, and the probability of near-term price declines is high. For a long-term investor, it may be better to wait for more favorable entry points or improved financial performance.
The stock's MACD is positive and expanding, indicating bullish momentum. However, the RSI is at 82.519, signaling the stock is overbought. Moving averages are converging, suggesting a potential trend reversal. Key resistance levels are at $97.409 and $101.878, with support at $82.943 and $78.474. The stock is currently trading above its pivot point, but overbought conditions and resistance levels may limit further upside.
Q4 earnings exceeded expectations with $958 million in revenue and adjusted EPS of $2.
Strong direct-to-consumer and international revenue growth.
Hedge funds are significantly increasing their positions in the stock.
Significant YoY declines in net income (-71.49%), EPS (-67.77%), and gross margin (-5.53%).
Analysts have downgraded the stock due to U.S. demand challenges, wholesale caution, and limited near-term catalysts.
Technical indicators suggest overbought conditions, with a high probability of near-term price declines.
In Q4 2025, Crocs reported revenue of $957.64 million, down -3.25% YoY. Net income dropped to $105.17 million (-71.49% YoY), and EPS fell to $2.05 (-67.77% YoY). Gross margin also declined to 54.68%, down -5.53% YoY. Despite these declines, the company generated strong free cash flow and highlighted growth opportunities for 2026.
Recent analyst ratings are mixed to negative. KeyBanc downgraded the stock to Sector Weight, citing U.S. demand challenges and limited visibility. Baird downgraded it to Neutral with a $100 price target. BWG Global upgraded its view to Mixed from Negative, citing positive checks in China and the U.S. Overall, analysts are cautious about near-term performance.
